APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,241,688 | -30.2% | 345,195 | +6.9% | 0.00% | -25.0% |
Q1 2024 | $18,981,348 | -14.8% | 322,922 | -13.3% | 0.00% | -20.0% |
Q4 2023 | $22,283,185 | +62.6% | 372,255 | +3.3% | 0.01% | +66.7% |
Q3 2023 | $13,705,318 | -57.9% | 360,287 | +0.8% | 0.00% | -57.1% |
Q2 2023 | $32,549,028 | +25.8% | 357,289 | -8.9% | 0.01% | +16.7% |
Q1 2023 | $25,882,440 | +23.6% | 392,396 | -3.1% | 0.01% | +20.0% |
Q4 2022 | $20,944,566 | -24.9% | 405,039 | -0.8% | 0.01% | -28.6% |
Q3 2022 | $27,898,000 | +77.2% | 408,459 | +17.3% | 0.01% | +75.0% |
Q2 2022 | $15,743,000 | -1.8% | 348,150 | +10.4% | 0.00% | +33.3% |
Q1 2022 | $16,029,000 | +13.7% | 315,480 | +5.8% | 0.00% | 0.0% |
Q4 2021 | $14,098,000 | +58.7% | 298,193 | +10.7% | 0.00% | +50.0% |
Q3 2021 | $8,882,000 | -46.4% | 269,484 | +2.8% | 0.00% | -33.3% |
Q2 2021 | $16,560,000 | +69.9% | 262,028 | +15.4% | 0.00% | +50.0% |
Q1 2021 | $9,746,000 | -33.0% | 227,134 | -10.6% | 0.00% | -33.3% |
Q4 2020 | $14,541,000 | +102.2% | 254,207 | +6.6% | 0.00% | +50.0% |
Q3 2020 | $7,191,000 | -9.6% | 238,360 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $7,957,000 | +23.7% | 243,640 | +1.5% | 0.00% | 0.0% |
Q1 2020 | $6,430,000 | +7.0% | 240,019 | +22.3% | 0.00% | 0.0% |
Q4 2019 | $6,008,000 | +31.2% | 196,199 | +3.2% | 0.00% | +100.0% |
Q3 2019 | $4,581,000 | -9.6% | 190,126 | -5.0% | 0.00% | 0.0% |
Q2 2019 | $5,069,000 | +53.2% | 200,057 | +17.9% | 0.00% | 0.0% |
Q1 2019 | $3,308,000 | +64.2% | 169,652 | +11.1% | 0.00% | 0.0% |
Q4 2018 | $2,015,000 | -20.6% | 152,720 | +7.0% | 0.00% | 0.0% |
Q3 2018 | $2,539,000 | -9.3% | 142,788 | +12.3% | 0.00% | 0.0% |
Q2 2018 | $2,798,000 | +262.9% | 127,167 | +264.5% | 0.00% | – |
Q1 2018 | $771,000 | +85.3% | 34,887 | +82.0% | 0.00% | – |
Q4 2017 | $416,000 | – | 19,166 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |